Panel Discussion: Contrasting Characterization Strategies Across Cell Therapy Modalities to Understand the Diversity of Cell Therapy Platforms
Time: 11:55 am
day: Track A - Cell Based Assay (Day Two - Morning)
Details:
- Explore the unique challenges and considerations in characterizing immunotherapy products, including antigen specificity, T-cell functionality, and cytokine secretion profiles.
- Compare and contrast characterization approaches between autologous and allogeneic cell therapies, examining donor variability, immune compatibility testing, and scalability considerations.
- Explore the complexities of characterizing gene therapy products, including the need for precise vector identity, potency, and purity assessments
